Aytu bioscience, inc (AYTU)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Feb'15Dec'14Nov'14Sep'14May'14Mar'14Feb'14Nov'13Aug'13May'13Feb'13Nov'12Aug'12May'12Feb'12Nov'11Aug'11May'11Feb'11Nov'10
Product revenue, net

-

-

-

-

-

-

-

-

607

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License revenue, net

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product revenue, net

-

-

-

-

-

-

-

-

-

1,051

1,076

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenues
Product and service revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

647

447

465

160

2

-

6

-

6

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

447

21

21

21

21

21

-

21

-

21

-

12

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product revenue

-

-

-

-

-

-

-

-

-

-

-

-

893

794

697

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenue

8,156

3,175

1,439

1,715

2,377

1,795

1,431

925

607

1,051

1,076

835

893

794

697

937

668

469

487

182

23

-

28

-

27

-

12

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product revenue, net

8,156

3,175

1,439

-

2,377

1,795

1,431

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses
Cost of sales

1,998

606

375

649

616

525

410

241

1,136

385

287

349

324

551

191

334

340

244

37

87

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

78

66

78

175

108

149

155

189

114

-277

140

185

279

263

232

2,819

1,143

1,308

855

801

694

-

789

-

933

-

1,237

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development - related party (Note 9)

-

-

-

-

-

-

-

-

-

-

-

0

291

47

47

47

47

47

47

47

47

-

53

-

53

-

28

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Selling, general and administrative

9,501

6,516

5,146

4,896

5,368

5,046

3,576

3,923

4,637

4,553

4,618

3,710

4,385

3,642

5,704

3,101

2,165

1,687

1,563

1,029

1,070

-

749

-

1,131

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Selling, general and administrative - related party

0

0

0

0

6

91

253

0

0

0

0

27

35

50

50

53

79

86

88

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of finite-lived intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

108

-

-

17

-

17

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of intangible assets

-

-

-

-

-

-

-

-

1,856

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of intangible assets

1,370

953

575

575

575

534

451

396

387

383

385

-

437

-

-

-

118

-

57

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization and impairment of intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

437

437

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

12,949

8,142

6,175

6,295

6,676

6,345

4,849

4,750

8,132

5,045

5,432

5,936

5,753

4,992

6,664

14,237

3,895

3,483

2,650

-

1,829

-

1,611

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

-

1

-

0

0

0

1

0

0

1

0

0

0

0

0

0

0

Professional fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

-

8

-

6

-

15

7

2

2

3

9

1

3

4

8

25

4

7

7

Contributed services, related party (Note 3)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

-

1

-

0

-

0

1

0

2

1

2

3

1

0

1

1

0

1

0

General and administrative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

-

5

-

5

737

4

6

5

9

8

6

14

5

4

8

44

14

18

8

Loss from operations

-4,793

-4,967

-4,735

-4,579

-4,298

-4,550

-3,417

-3,825

-7,524

-3,993

-4,356

-5,100

-4,859

-4,198

-5,966

-13,299

-3,227

-3,014

-2,163

-2,151

-1,806

-9

-1,583

-15

-2,091

-11

-

-20

-15

-9

-11

-12

-18

-17

-11

-9

-18

-70

-20

-26

-16

Other (expense) income
Other (expense), net

538

446

195

136

194

127

76

177

186

196

188

1,650

80

388

415

1,063

4,074

240

113

4

36

0

37

0

37

0

11

1

1

1

1

1

1

0

0

0

0

3

0

0

-1

Gain from derecognition of contingent consideration

0

5,199

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized gain on investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Loss) on investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized gain on investment

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Loss) on investment

-

-

-

-

-

-

-

-

-

-

-

0

-292

-497

728

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9

-

15

-

12

2,003

20

15

9

13

12

18

18

11

9

18

70

20

26

16

Other gain

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

0

-

0

-

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Gain from warrant derivative liability

0

0

1

-9,896

-2

20

47

2,320

3,139

518

299

-0

16

266

-70

37

27

-78

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain from warrant derivative liability

-

-

-

-

-

-

-

-

1,753

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other (expense) income

-538

4,752

-193

-9,951

-197

-106

-29

4,373

4,706

321

110

-1,650

-356

-618

242

-1,997

-4,046

-318

-113

-4

-36

-0

-37

-0

-37

-0

-11

-1

-1

-1

-1

-1

-1

-0

-0

-0

-0

-0

-0

-0

-1

Net loss, before income tax

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,332

-

-2,155

-1,842

-

-1,620

-

-2,128

-

-2,002

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred income tax benefit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

-

-23

-

-322

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-5,332

-214

-4,929

-14,531

-4,495

-4,657

-3,446

547

-2,817

-3,672

-4,245

-6,750

-5,216

-4,817

-5,724

-15,297

-7,274

-3,332

-2,276

-2,155

-1,842

-9

-1,620

-15

-2,105

-11

-1,680

-22

-16

-10

-13

-13

-19

-17

-11

-10

-19

-71

-20

-26

-17

Weighted average number of common shares outstanding

35,275

17,538

15,325

13,880

9,061

6,477

1,759

1,743

592

205

120

679

546

392

244

-3,597

1,569

1,188

1,188

-20,634

7,901

-

7,901

-

7,901

-

44,652

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted net loss per common share

-0.15

-0.03

-0.32

-0.30

-0.50

-0.72

-1.96

42.45

-4.75

-17.86

-35.15

-3.12

-9.54

-12.27

-23.37

-314.34

-4.64

-2.80

-1.92

-9.36

-0.23

0.00

-0.21

0.00

-0.27

0.00

-0.04

0.00

0.00

-0.01

0.00

0.00

0.00

-0.01

0.00

0.00

0.00

-0.01

0.00

-0.01

-0.01

Basic and diluted weighted average common shares outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,835

-

5,754

-

5,117

-

4,917

4,916

-

4,889

4,889

4,863

-

4,837

4,789

4,762

4,513

4,215

4,098

3,489

Product Revenue
Total revenue

8,156

-

-

-

2,372

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License Revenue
Total revenue

0

-

-

-

5

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-